FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older WHITEHOUSE STATION, N.J., Jun ...
FDA approved Merck’s Dulera, a combination inhaler, for asthma patients 12 years and older, the company announced today. Dulera consists of an inhaled corticosteroid and a long-acting beta agonist, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback